Novalis LifeSciences
Venture capitalPortsmouth · Seed–Late Stage · 9 people tracked
Investment thesis
Novalis Advisory provides strategic advisory and investment banking services, including consulting on business organization and operations, financial and management matters, and executive and leadership development training and coaching.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 18 of 18 portfolio companiesBiotech ×13Healthtech ×10Medical Devices ×10AI & Machine Learning ×9Deep Tech ×8Digital Health ×4AgTech ×3Hardware ×3
HQs:United States×13
Investments · 18 tracked
founders shown can be your intro pathBy year:2025 · 22023 · 12022 · 12021 · 12020 · 22019 · 12017 · 19 dated
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)
BoardJohn Connolly(Director)Keith Crandell(Director)
Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019
Co-investorsARCH Venture PartnersFoothill VenturesKhosla Ventures
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Andrew Calabrese(Scientific Co-Founder)Douglas E. Hutchens(CSO)Logan Andrews(Head of Program Management)Philip Austin(Co-founder (Managing Partner, Anterra Capital))Andrew Plant(Executive Officer, Director)
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAnterra CapitalDYDX Capital
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Director)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsReimagined VenturesAlumni VenturesArtis VenturesBasecamp FundCastor Ventures (an Alumni Ventures Fund)Cota Capital+8 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Board seatMarijn Dekkers· per SEC Form D · $117.2M raise · filed Feb 2022
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersPolaris Partners
BiotechBoston, US
Jacqueline Heard(Executive Officer, Director)Philip Austin(Director)Steffen Helmling(Director)
Board seatMarijn Dekkers· per SEC Form D · $80M raise · filed Dec 2022
Co-investorsCastor Ventures (an Alumni Ventures Fund)
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Co-investors8VCBeringeaGreat North VenturesIntuitive VenturesiSelect FundLightbank+2 more
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021
Co-investorsARCH Venture PartnersM VenturesNorthpond Ventures
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotech
Tom Meade(Chief Science Officer)
Co-investorsConnecticut InnovationsDYDX CapitalEndeavor8Germin8 VenturesAnterra CapitalEight Roads Ventures+1 more
Flywheel provides a building operations platform for facility and property managers to manage maintenance teams, track preventative and ad hoc tasks, and analyze energy usage.
CleantechEnergyPropTechSaaSDallas, US
Steve Gossett, Jr.(CEO)Brian BezdekBrian Ratcliff
Co-investorsBraemar Energy Ventures8VCNVIDIA
LeviCell develops the LeviCell EOS system, an instrument used in single-cell RNA sequencing (scRNA-seq) workflows to visually assess and quality-control samples before they are loaded onto downstream sequencing platforms.
BiotechDeep TechHardware
Co-investorsDecheng Capital
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical Devices
Paul Blavin(Co-Founder & Vice Chairman)Dawn Mattoon, PhD(Chief Executive Officer)
Co-investorsHatteras Venture PartnersiSelect FundMindshift CapitalPortfoliaSozo VenturesThe Perkins Fund
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersKindred CapitalPuhua Capital
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases.
AI & Machine LearningBiotechDeep TechMedical Devices
Mark Pykett(Chief Executive Officer)
SkylineDx develops gene-based diagnostic tests that identify how patients will respond to treatment by analyzing genomic alterations in disease cells, serving oncology and dermatology care providers and patients.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Diego, US
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)William F. Snider(Director)Andrea L. Jackson(Director)Christine A. Tsingos(Director)
BiotechDigital HealthHealthtechMedical DevicesMiami, US
Matthew H. J. Kim(Executive Officer, Director)
BoardTimothy Barabe(Director)Eric Stone(Director)Jonathan T. Lord(Director)Jeffrey Goodman(Director)
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtech
Kris ElveruminTodd Bazemore(Chief Executive Officer)
BoardRodger Novak(Chair)
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioQuanterixNASDAQ: QTRX
Portfolio news
latest coverage across their companiesFlywheel · seekingalpha.com · Aug 19, 2026
Quanterix · investing.com · Aug 17, 2026
Activ Surgical · nasdaqprivatemarket.com · Apr 2, 2026
Vizgen · intelligence360.news · Feb 2, 2026
Enko Website · globenewswire.com · Nov 22, 2025
Mercy BioAnalytics · trial.medpath.com · Sep 5, 2025
Frequently asked questions
- How many investments has Novalis LifeSciences made?
- Novalis LifeSciences has 12 tracked investments, including 2 dated in the last 24 months.
- What stage does Novalis LifeSciences invest at?
- Novalis LifeSciences invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Novalis LifeSciences focus on?
- Novalis LifeSciences focuses on Biotech, Healthtech, Medical Devices.
- Where is Novalis LifeSciences located?
- Novalis LifeSciences is headquartered in Portsmouth, US.
- Who does Novalis LifeSciences co-invest with?
- Novalis LifeSciences most often shares deals with DYDX Capital, iSelect Fund, 8VC, among 24 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Pappas Capital is a life sciences venture capital firm that invests in and helps build companies developing next-generation life science products and technologies.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.
JSTAR Capital Investments is a healthcare-focused investment firm backing medical technology companies, providing capital and expert guidance to advance patient care and address global healthcare challenges.
New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that backs companies applying novel scientific approaches in the life sciences and information technology sectors.